Disentangling fetal and maternal susceptibility for pre-eclampsia: A British multicenter candidate-gene study

Linda Morgan*, M. Farrall, P. N. Baker, F. Broughton Pipkin, N. Kalsheker, S. O’Malley, M. Henfrey, S. Arulkumaran, I. Symonds, A. Cameron, A. Dominiczak, M. McDade, W. Kwong Lee, J. McCulloch, M. Caulfield, M. Habiba, C. Dodd, M. Kilby, L. Davies, S. MacphailP. M.S. O’Brien, K. O’Shaughnessy, B. Newcombe, P. De La Salle, C. Redman, P. Jarrett, M. De Swiet, C. Williamson, E. Byford, F. Cheng, J. J. Walker, L. Samwiil, G. Chapman, E. Dennehy, R. Keys, S. Bjornsson, C. Mercer, M. Mohajer, G. Thompson, M. N. Fitzgibbon, G. Hackett, K. Hinshaw, B. Lim, D. T.Y. Liu, W. Mackenzie, M. Selinger, I. Scudamore, C. Sparey, D. Tuffnell, S. Ward, The GOPEC Consortium

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

92 Citations (Scopus)

Abstract

The Genetics of Pre-Eclampsia (GOPEC) collaboration aims to identify genetic factors in U.K. families affected by pre-eclampsia. A number of genetic studies have reported associations with pre-eclampsia, but attempts to replicate these findings have yielded inconsistent results. We describe the results of extensive genotyping of seven candidate genes previously reported as conferring susceptibility to pre-eclampsia. Six hundred fifty-seven women affected by pre-eclampsia and their families were genotyped at 28 single-nucleotide polymorphisms in the genes encoding angiotensinogen, the angiotensin receptors, factor V Leiden variant, methylene tetrahydrofolate reductase, nitric oxide synthase, and TNFα. Genotypes were analyzed by the transmission/disequilibrium test. Genotype risk ratios (GRRs) associated with maternal genotypes had a range of 0.70−1.16; GRRs associated with fetal genotypes had a range of 0.72−1.11. No GRR achieved the prespecified criteria for statistical significance (posterior probability >.05). We conclude that none of the genetic variants tested in this large study of strictly defined pre-eclamptic pregnancies confers a high risk of disease. The results emphasize the importance of conducting rigorously designed studies of adequate size to provide precise genetic risks with narrow confidence intervals, if overreporting of falsepositive results is to be avoided.

Original languageEnglish
Pages (from-to)127-131
Number of pages5
JournalAmerican Journal of Human Genetics
Volume77
Issue number1
Early online date11 May 2005
DOIs
Publication statusPublished - Jul 2005
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2005 by The American Society of Human Genetics.

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Fingerprint

Dive into the research topics of 'Disentangling fetal and maternal susceptibility for pre-eclampsia: A British multicenter candidate-gene study'. Together they form a unique fingerprint.

Cite this